Innovent to Present at 41st Annual J.P. Morgan Healthcare Conference
- Written by PR Newswire
ROCKVILLE, Md. and SUZHOU, China, Jan. 5, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and other major diseases, today...
Read more: Innovent to Present at 41st Annual J.P. Morgan Healthcare Conference














